C/EBPα and MYB regulate FLT3 expression in AML

Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα

(2012) Hanna S. Radomska et al.   JOURNAL OF CLINICAL INVESTIGATION

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model

(2012) K Reckzeh et al.   LEUKEMIA

Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis

(2011) J. Fos et al.   BLOOD

Identification and characterization of Hoxa9 binding sites in hematopoietic cells

(2011) Y. Huang et al.   BLOOD

Two types of C/EBP  mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models

(2010) N. Kato et al.   BLOOD

FLT3 as a therapeutic target in AML: still challenging after all these years

(2010) T. Kindler et al.   BLOOD

The Transcription Factor PU.1 Controls Dendritic Cell Development and Flt3 Cytokine Receptor Expression in a Dose-Dependent Manner

(2010) Sebastian Carotta et al.   IMMUNITY

B-Myb is Critical for Proper DNA Duplication During an Unperturbed S Phase in Mouse Embryonic Stem Cells

(2010) Maëlle Lorvellec et al.   STEM CELLS

The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication

(2009) A. Renneville et al.   BLOOD

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

(2009) B. J. Wouters et al.   BLOOD

Complexity of CEBPA Dysregulation in Human Acute Myeloid Leukemia

(2009) T. Pabst et al.   CLINICAL CANCER RESEARCH

Structural and Functional Alterations of FLT3 in Acute Myeloid Leukemia

(2009) S. Meshinchi et al.   CLINICAL CANCER RESEARCH

Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome

(2009) Annika Dufour et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics

(2009) Tara K Gregory et al.   Journal of Hematology & Oncology

Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation

(2009) Y. K. Lieu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mutation of C/EBP  predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen

(2008) M. S. Hasemann et al.   BLOOD

Requirement of c-Myb for p210BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis

(2008) M. R. Lidonnici et al.   BLOOD

An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML

(2008) L. Bullinger et al.   BLOOD